Skin adnexal carcinomas DNA genomic profiling uncovers oncogenic pathways and potential therapeutic targets
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-01-01
|
| Series: | EJC Skin Cancer |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772611824001940 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846159055429566464 |
|---|---|
| author | B. Louveau I. Nakouri F. Jouenne B. Baroudjian A. Sadoux L. Da Meda A. Osio F. Reinhart J. Robert M. Mancini F. Herms B. Cribier L. Mortier T. Jouary N. Basset-Seguin C. Lebbé S. Mourah M. Battistella |
| author_facet | B. Louveau I. Nakouri F. Jouenne B. Baroudjian A. Sadoux L. Da Meda A. Osio F. Reinhart J. Robert M. Mancini F. Herms B. Cribier L. Mortier T. Jouary N. Basset-Seguin C. Lebbé S. Mourah M. Battistella |
| author_sort | B. Louveau |
| collection | DOAJ |
| format | Article |
| id | doaj-art-c4ba41198e2a4bc0bf6278b87efe3515 |
| institution | Kabale University |
| issn | 2772-6118 |
| language | English |
| publishDate | 2024-01-01 |
| publisher | Elsevier |
| record_format | Article |
| series | EJC Skin Cancer |
| spelling | doaj-art-c4ba41198e2a4bc0bf6278b87efe35152024-11-24T04:15:14ZengElsevierEJC Skin Cancer2772-61182024-01-012100206Skin adnexal carcinomas DNA genomic profiling uncovers oncogenic pathways and potential therapeutic targetsB. Louveau0I. Nakouri1F. Jouenne2B. Baroudjian3A. Sadoux4L. Da Meda5A. Osio6F. Reinhart7J. Robert8M. Mancini9F. Herms10B. Cribier11L. Mortier12T. Jouary13N. Basset-Seguin14C. Lebbé15S. Mourah16M. Battistella17Assistance Publique - Hopitaux de Paris, Hopital Saint-Louis, Department of Pharmacology and Tumor Genomics, Paris, France; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, FranceUniversité Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France; Assistance Publique - Hopitaux de Paris, Hopital Saint Louis, Department of Dermatology, Paris, FranceAssistance Publique - Hopitaux de Paris, Hopital Saint-Louis, Department of Pharmacology and Tumor Genomics, Paris, France; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, FranceAssistance Publique - Hopitaux de Paris, Hopital Saint Louis, Department of Dermatology, Paris, FranceAssistance Publique - Hopitaux de Paris, Hopital Saint-Louis, Department of Pharmacology and Tumor Genomics, Paris, FranceAssistance Publique - Hopitaux de Paris, Hopital Saint Louis, Department of Dermatology, Paris, FranceFrench Network of Rare Skin Cancers, CARADERM, Paris, France; CND-Paris la Roquette, Ivry, France; Assistance Publique - Hopitaux de Paris, Hopital Saint-Louis, Department of Pathology, Paris, FranceAssistance Publique - Hopitaux de Paris, Hopital Saint-Louis, Department of Pathology, Paris, FranceAssistance Publique - Hopitaux de Paris, Hopital Saint-Louis, DMU Biogem, Paris, FranceAssistance Publique - Hopitaux de Paris, Hopital Saint-Louis, Department of Pharmacology and Tumor Genomics, Paris, FranceAssistance Publique - Hopitaux de Paris, Hopital Saint Louis, Department of Dermatology, Paris, FranceFrench Network of Rare Skin Cancers, CARADERM, Paris, France; University of Strasbourg, Dermatology and Dermatopathology, Faculty of Medicine, University Hospital, Strasbourg, FranceFrench Network of Rare Skin Cancers, CARADERM, Paris, France; Claude Huriez Hospital and University of Lille, Department of Dermatology, Lille, FranceFrench Network of Rare Skin Cancers, CARADERM, Paris, France; Hospital Center of Pau, Department of Dermatology, Pau, FranceAssistance Publique - Hopitaux de Paris, Hopital Saint Louis, Department of Dermatology, Paris, FranceUniversité Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France; Assistance Publique - Hopitaux de Paris, Hopital Saint Louis, Department of Dermatology, Paris, FranceAssistance Publique - Hopitaux de Paris, Hopital Saint-Louis, Department of Pharmacology and Tumor Genomics, Paris, France; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, FranceUniversité Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France; Assistance Publique - Hopitaux de Paris, Hopital Saint-Louis, Department of Pathology, Paris, France; French Network of Rare Skin Cancers, CARADERM, Paris, Francehttp://www.sciencedirect.com/science/article/pii/S2772611824001940 |
| spellingShingle | B. Louveau I. Nakouri F. Jouenne B. Baroudjian A. Sadoux L. Da Meda A. Osio F. Reinhart J. Robert M. Mancini F. Herms B. Cribier L. Mortier T. Jouary N. Basset-Seguin C. Lebbé S. Mourah M. Battistella Skin adnexal carcinomas DNA genomic profiling uncovers oncogenic pathways and potential therapeutic targets EJC Skin Cancer |
| title | Skin adnexal carcinomas DNA genomic profiling uncovers oncogenic pathways and potential therapeutic targets |
| title_full | Skin adnexal carcinomas DNA genomic profiling uncovers oncogenic pathways and potential therapeutic targets |
| title_fullStr | Skin adnexal carcinomas DNA genomic profiling uncovers oncogenic pathways and potential therapeutic targets |
| title_full_unstemmed | Skin adnexal carcinomas DNA genomic profiling uncovers oncogenic pathways and potential therapeutic targets |
| title_short | Skin adnexal carcinomas DNA genomic profiling uncovers oncogenic pathways and potential therapeutic targets |
| title_sort | skin adnexal carcinomas dna genomic profiling uncovers oncogenic pathways and potential therapeutic targets |
| url | http://www.sciencedirect.com/science/article/pii/S2772611824001940 |
| work_keys_str_mv | AT blouveau skinadnexalcarcinomasdnagenomicprofilinguncoversoncogenicpathwaysandpotentialtherapeutictargets AT inakouri skinadnexalcarcinomasdnagenomicprofilinguncoversoncogenicpathwaysandpotentialtherapeutictargets AT fjouenne skinadnexalcarcinomasdnagenomicprofilinguncoversoncogenicpathwaysandpotentialtherapeutictargets AT bbaroudjian skinadnexalcarcinomasdnagenomicprofilinguncoversoncogenicpathwaysandpotentialtherapeutictargets AT asadoux skinadnexalcarcinomasdnagenomicprofilinguncoversoncogenicpathwaysandpotentialtherapeutictargets AT ldameda skinadnexalcarcinomasdnagenomicprofilinguncoversoncogenicpathwaysandpotentialtherapeutictargets AT aosio skinadnexalcarcinomasdnagenomicprofilinguncoversoncogenicpathwaysandpotentialtherapeutictargets AT freinhart skinadnexalcarcinomasdnagenomicprofilinguncoversoncogenicpathwaysandpotentialtherapeutictargets AT jrobert skinadnexalcarcinomasdnagenomicprofilinguncoversoncogenicpathwaysandpotentialtherapeutictargets AT mmancini skinadnexalcarcinomasdnagenomicprofilinguncoversoncogenicpathwaysandpotentialtherapeutictargets AT fherms skinadnexalcarcinomasdnagenomicprofilinguncoversoncogenicpathwaysandpotentialtherapeutictargets AT bcribier skinadnexalcarcinomasdnagenomicprofilinguncoversoncogenicpathwaysandpotentialtherapeutictargets AT lmortier skinadnexalcarcinomasdnagenomicprofilinguncoversoncogenicpathwaysandpotentialtherapeutictargets AT tjouary skinadnexalcarcinomasdnagenomicprofilinguncoversoncogenicpathwaysandpotentialtherapeutictargets AT nbassetseguin skinadnexalcarcinomasdnagenomicprofilinguncoversoncogenicpathwaysandpotentialtherapeutictargets AT clebbe skinadnexalcarcinomasdnagenomicprofilinguncoversoncogenicpathwaysandpotentialtherapeutictargets AT smourah skinadnexalcarcinomasdnagenomicprofilinguncoversoncogenicpathwaysandpotentialtherapeutictargets AT mbattistella skinadnexalcarcinomasdnagenomicprofilinguncoversoncogenicpathwaysandpotentialtherapeutictargets |